• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通用GPCR残基编号——在留意缺口的同时对齐拓扑图。

Generic GPCR residue numbers - aligning topology maps while minding the gaps.

作者信息

Isberg Vignir, de Graaf Chris, Bortolato Andrea, Cherezov Vadim, Katritch Vsevolod, Marshall Fiona H, Mordalski Stefan, Pin Jean-Philippe, Stevens Raymond C, Vriend Gerrit, Gloriam David E

机构信息

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Division of Medicinal Chemistry, Faculty of Sciences, Amsterdam Institute for Molecules, Medicines and Systems, VU University Amsterdam, The Netherlands.

出版信息

Trends Pharmacol Sci. 2015 Jan;36(1):22-31. doi: 10.1016/j.tips.2014.11.001. Epub 2014 Dec 22.

DOI:10.1016/j.tips.2014.11.001
PMID:25541108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4408928/
Abstract

Generic residue numbers facilitate comparisons of, for example, mutational effects, ligand interactions, and structural motifs. The numbering scheme by Ballesteros and Weinstein for residues within the class A GPCRs (G protein-coupled receptors) has more than 1100 citations, and the recent crystal structures for classes B, C, and F now call for a community consensus in residue numbering within and across these classes. Furthermore, the structural era has uncovered helix bulges and constrictions that offset the generic residue numbers. The use of generic residue numbers depends on convenient access by pharmacologists, chemists, and structural biologists. We review the generic residue numbering schemes for each GPCR class, as well as a complementary structure-based scheme, and provide illustrative examples and GPCR database (GPCRDB) web tools to number any receptor sequence or structure.

摘要

通用残基编号便于进行例如突变效应、配体相互作用和结构基序等方面的比较。巴列斯特罗斯和温斯坦针对A类G蛋白偶联受体(GPCRs)内的残基所采用的编号方案已有超过1100次引用,而最近B、C和F类GPCRs的晶体结构现在要求在这些类别内部和类别之间就残基编号达成社区共识。此外,结构时代已经发现了螺旋凸起和收缩,这使得通用残基编号出现了偏差。通用残基编号的使用依赖于药理学家、化学家和结构生物学家能够方便地获取。我们回顾了每个GPCR类别以及一个基于结构的补充编号方案的通用残基编号方案,并提供了说明性示例和GPCR数据库(GPCRDB)网络工具,用于对任何受体序列或结构进行编号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/f498dd5dfd24/nihms675616f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/e28031c58c62/nihms675616f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/3f093c76d1c7/nihms675616f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/345bb925016e/nihms675616f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/4dddbf9e6b60/nihms675616f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/f498dd5dfd24/nihms675616f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/e28031c58c62/nihms675616f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/3f093c76d1c7/nihms675616f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/345bb925016e/nihms675616f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/4dddbf9e6b60/nihms675616f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7855/4408928/f498dd5dfd24/nihms675616f5.jpg

相似文献

1
Generic GPCR residue numbers - aligning topology maps while minding the gaps.通用GPCR残基编号——在留意缺口的同时对齐拓扑图。
Trends Pharmacol Sci. 2015 Jan;36(1):22-31. doi: 10.1016/j.tips.2014.11.001. Epub 2014 Dec 22.
2
A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?G蛋白偶联受体化学基因组学的结构框架:残基编号蕴含着什么信息?
Methods Mol Biol. 2018;1705:73-113. doi: 10.1007/978-1-4939-7465-8_4.
3
GPCRdb: an information system for G protein-coupled receptors.GPCRdb:G蛋白偶联受体信息系统。
Nucleic Acids Res. 2016 Jan 4;44(D1):D356-64. doi: 10.1093/nar/gkv1178. Epub 2015 Nov 17.
4
Generic residue numbering of the GAIN domain of adhesion GPCRs.粘附性G蛋白偶联受体(GPCR)的GAIN结构域的通用残基编号。
Nat Commun. 2025 Jan 2;16(1):246. doi: 10.1038/s41467-024-55466-6.
5
GPCRDB: an information system for G protein-coupled receptors.GPCRDB:一个 G 蛋白偶联受体的信息系统。
Nucleic Acids Res. 2014 Jan;42(Database issue):D422-5. doi: 10.1093/nar/gkt1255. Epub 2013 Dec 3.
6
Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications.所有人类G蛋白偶联受体跨膜结构域基于结构的序列比对:系统发育、结构和功能意义
PLoS Comput Biol. 2016 Mar 30;12(3):e1004805. doi: 10.1371/journal.pcbi.1004805. eCollection 2016 Mar.
7
GPCRdb in 2018: adding GPCR structure models and ligands.GPCRdb 在 2018 年:增加 GPCR 结构模型和配体。
Nucleic Acids Res. 2018 Jan 4;46(D1):D440-D446. doi: 10.1093/nar/gkx1109.
8
GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources.2023 年的 GPCRdb:使用 AlphaFold2 和新配体资源的特定状态结构模型。
Nucleic Acids Res. 2023 Jan 6;51(D1):D395-D402. doi: 10.1093/nar/gkac1013.
9
GPCRDB: information system for G protein-coupled receptors.GPCRDB:G蛋白偶联受体信息系统。
Nucleic Acids Res. 2011 Jan;39(Database issue):D309-19. doi: 10.1093/nar/gkq1009. Epub 2010 Nov 2.
10
ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs.ss-TEA:基于熵的 A 类 GPCR 多重序列比对中受体特异性配体结合残基的鉴定。
BMC Bioinformatics. 2011 Aug 10;12:332. doi: 10.1186/1471-2105-12-332.

引用本文的文献

1
Molecular basis of ligand binding and receptor activation at the human A adenosine receptor.人类A1腺苷受体配体结合及受体激活的分子基础
Nat Commun. 2025 Aug 18;16(1):7674. doi: 10.1038/s41467-025-62872-x.
2
Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF receptor heterotetramer.μ-阿片受体-促肾上腺皮质激素释放因子(CRF)受体异源四聚体的独特生化特性。
Pharmacol Res. 2025 Aug 8;219:107904. doi: 10.1016/j.phrs.2025.107904.
3
Effect of enhanced early life nutrition on the molecular regulation of anterior pituitary function in Holstein Friesian bull calves.

本文引用的文献

1
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges.通过2013年GPCR对接评估所评价的G蛋白偶联受体(GPCR)建模进展:迎接新挑战
Structure. 2014 Aug 5;22(8):1120-1139. doi: 10.1016/j.str.2014.06.012. Epub 2014 Jul 24.
2
Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain.C 类 G 蛋白偶联受体代谢型谷氨酸受体 5 的跨膜结构域。
Nature. 2014 Jul 31;511(7511):557-62. doi: 10.1038/nature13396. Epub 2014 Jul 6.
3
Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs.
早期强化营养对荷斯坦弗里生公牛犊垂体前叶功能分子调控的影响。
Sci Rep. 2025 Jul 1;15(1):20897. doi: 10.1038/s41598-025-04176-0.
4
Multiple intramolecular triggers converge to preferential G protein coupling in the CBR.多种分子内触发因素汇聚,导致CBR中优先的G蛋白偶联。
Nat Commun. 2025 Jun 11;16(1):5265. doi: 10.1038/s41467-025-60003-0.
5
Comparing models and experimental structures of the GPR101 receptor: Artificial intelligence yields highly accurate models.比较GPR101受体的模型与实验结构:人工智能生成高度精确的模型。
J Mol Graph Model. 2025 Nov;140:109103. doi: 10.1016/j.jmgm.2025.109103. Epub 2025 Jun 3.
6
Loss-of-function Gα rare disease variants exert mutation-specific effects on GPCR signaling.功能丧失型Gα罕见病变体对GPCR信号传导产生突变特异性影响。
Sci Signal. 2025 May 20;18(887):eado7543. doi: 10.1126/scisignal.ado7543.
7
G Protein Selectivity in Dopamine Receptors is Determined before GDP Release.多巴胺受体中G蛋白的选择性在GDP释放之前就已确定。
Biochemistry. 2025 Jun 3;64(11):2439-2454. doi: 10.1021/acs.biochem.4c00779. Epub 2025 May 13.
8
Allosteric communication mechanism in the glucagon receptor.胰高血糖素受体中的变构通讯机制。
J Biol Chem. 2025 Apr 23;301(6):108530. doi: 10.1016/j.jbc.2025.108530.
9
Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network.人类趋化因子 - G 蛋白偶联受体相互作用网络中的编码与解码选择性及混杂性
Cell. 2025 Jun 26;188(13):3603-3622.e27. doi: 10.1016/j.cell.2025.03.046. Epub 2025 Apr 23.
10
High-resolution deep mutational scanning of the melanocortin-4 receptor enables target characterization for drug discovery.黑素皮质素-4受体的高分辨率深度突变扫描可为药物发现提供靶点特征。
Elife. 2025 Apr 9;13:RP104725. doi: 10.7554/eLife.104725.
平滑受体调节及抗癌药物化学抗性的结构基础
Nat Commun. 2014 Jul 10;5:4355. doi: 10.1038/ncomms5355.
4
Alpha-bulges in G protein-coupled receptors.G 蛋白偶联受体中的α-隆起。
Int J Mol Sci. 2014 May 6;15(5):7841-64. doi: 10.3390/ijms15057841.
5
Structure of Class B GPCRs: new horizons for drug discovery.B类G蛋白偶联受体的结构:药物发现的新视野。
Br J Pharmacol. 2014 Jul;171(13):3132-45. doi: 10.1111/bph.12689.
6
Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.结构的一类 C G 蛋白偶联受体代谢型谷氨酸受体 1 结合到一个变构调节剂。
Science. 2014 Apr 4;344(6179):58-64. doi: 10.1126/science.1249489. Epub 2014 Mar 6.
7
Unifying family A GPCR theories of activation.统一家族 A G 蛋白偶联受体的激活理论。
Pharmacol Ther. 2014 Jul;143(1):51-60. doi: 10.1016/j.pharmthera.2014.02.004. Epub 2014 Feb 19.
8
mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discovery.代谢型谷氨酸受体5:正构和变构配体结合口袋的探索及其在药物发现中的应用。
Neurochem Res. 2014 Oct;39(10):1862-75. doi: 10.1007/s11064-014-1248-8. Epub 2014 Feb 4.
9
Insights into the structure of class B GPCRs.B 类 G 蛋白偶联受体结构研究进展。
Trends Pharmacol Sci. 2014 Jan;35(1):12-22. doi: 10.1016/j.tips.2013.11.001. Epub 2013 Dec 18.
10
GPCRDB: an information system for G protein-coupled receptors.GPCRDB:一个 G 蛋白偶联受体的信息系统。
Nucleic Acids Res. 2014 Jan;42(Database issue):D422-5. doi: 10.1093/nar/gkt1255. Epub 2013 Dec 3.